AstraZeneca (AZN) ASCO Data Increases Confidence in Enhertu - BofA Securities
Tweet Send to a Friend
BofA Securities analyst Sachin Jain reiterated a Buy rating and $80.00 price target on AstraZeneca (NASDAQ: AZN) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
